Literature DB >> 12003782

Transgenic expression of protein phosphatase 2A regulatory subunit B56gamma disrupts distal lung differentiation.

Allen D Everett1, Craig Kamibayashi, David L Brautigan.   

Abstract

The distal epithelium of the developing lung exhibits high-level expression of protein phosphatase 2A (PP2A), a vital signaling enzyme. Here we report the discovery that in the lung, the PP2A regulatory subunit B56gamma is expressed in a discrete developmental period, with the highest protein levels at embryonic day (e) 17, but no detectable protein in the newborn or adult. By in situ hybridization, B56gamma was highly expressed in the distal epithelium of newly forming airways and in mesenchymal cells. In contrast, expression of B56gamma was quite low in the bronchial epithelium and vascular smooth muscle. Transgenic expression of B56gamma using the lung-specific promoter for surfactant protein C (SP-C) resulted in neonatal death. Examination of lungs from SP-C-B56gamma transgenic e18 fetuses revealed proximal airways and normal blood vessels, but the tissue was densely populated with epithelial-type cells and was devoid of normal peripheral lung structure. A component of the Wnt signaling pathway, beta-catenin, was developmentally regulated in the normal lung and was absent in lung tissue from B-56gamma transgenic fetuses. We propose that B56gamma is expressed at a particular stage of lung development to modulate PP2A action on the Wnt/beta-catenin signaling pathway during lung airway morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003782     DOI: 10.1152/ajplung.00262.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  9 in total

1.  Wnt signaling in lung organogenesis.

Authors:  Stijn P De Langhe; Susan D Reynolds
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

Review 2.  Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.

Authors:  Parthasarathy Seshacharyulu; Poomy Pandey; Kaustubh Datta; Surinder K Batra
Journal:  Cancer Lett       Date:  2013-02-20       Impact factor: 8.679

Review 3.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

Review 4.  The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.

Authors:  Peter P Ruvolo
Journal:  BBA Clin       Date:  2016-08-03

5.  FAM122A, a new endogenous inhibitor of protein phosphatase 2A.

Authors:  Li Fan; Man-Hua Liu; Meng Guo; Chuan-Xi Hu; Zhao-Wen Yan; Jing Chen; Guo-Qiang Chen; Ying Huang
Journal:  Oncotarget       Date:  2016-09-27

Review 6.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

7.  Identification of a novel conserved mixed-isoform B56 regulatory subunit and spatiotemporal regulation of protein phosphatase 2A during Xenopus laevis development.

Authors:  Sungmin Baek; Joni M Seeling
Journal:  BMC Dev Biol       Date:  2007-12-19       Impact factor: 1.978

Review 8.  From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.

Authors:  Maria Ciccone; George A Calin; Danilo Perrotti
Journal:  Front Oncol       Date:  2015-02-16       Impact factor: 6.244

9.  The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model.

Authors:  Mahnaz Janghorban; Ellen M Langer; Xiaoyan Wang; Derek Zachman; Colin J Daniel; Jody Hooper; William H Fleming; Anupriya Agarwal; Rosalie C Sears
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.